Skip to content
  • Tuesday, 30 June 2026
  • 3:38 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Arrowhead Pharmaceuticals Secures Australian TGA Approval for Redemplo, Offering Hope for Familial Chylomicronemia Syndrome Patients
Pharmaceutical R&D

Arrowhead Pharmaceuticals Secures Australian TGA Approval for Redemplo, Offering Hope for Familial Chylomicronemia Syndrome Patients

Teuku Ryan May 4, 2026 0

The Australian Therapeutic Goods Administration (TGA) has granted approval for Arrowhead Pharmaceuticals’ Redemplo (plozasiran), a novel therapeutic agent designed to…

Read More
Science News: A Century of Empowering Public Understanding of ScienceTWiV 1291: A Foot in the Door for Cytomegalovirus and a Neurovirulent Poliovirus Emergence in UgandaNorthwestern University Engineers Develop Printed Artificial Neurons Capable of Direct Interaction with Biological Brain CellsUS FDA Grants Priority Review to Bristol Myers Squibb’s Camzyos for Adolescent Patients with Obstructive Hypertrophic Cardiomyopathy
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
The Genetic Legacy of Paternal Aging: How Intra-Testicular Selection Drives Disease-Causing Mutations in SpermPens to pills: what oral GLP-1s change at the benchArc Protein Identified as Key Driver in the Spread of Toxic Tau Proteins in Alzheimer’s DiseaseTalawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
The Genetic Legacy of Paternal Aging: How Intra-Testicular Selection Drives Disease-Causing Mutations in Sperm
Dwi Wanna Jun 30, 2026
Laboratory Automation & Robotics
Pens to pills: what oral GLP-1s change at the bench
Lana Keisha Jun 30, 2026
Neuroscience & Brain Research
Arc Protein Identified as Key Driver in the Spread of Toxic Tau Proteins in Alzheimer’s Disease
Rifan Muazin Jun 30, 2026
Pharmaceutical R&D
Talawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics
Teuku Ryan Jun 30, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ